/Medtronic%20Plc%20logo-by%20360b%20via%20Shutterstock.jpg)
Minneapolis, Minnesota-based Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. With a market cap of $115.6 billion, Medtronic operates through Cardiovascular, Medical Surgical, Neuroscience and Diabetes segments.
Medtronic has lagged behind the broader market over the past year. MDT stock is up 9.4% on a YTD basis and 22.7% over the past year compared to the S&P 500 Index’s ($SPX) surge of 24.3% on a YTD basis and 35.8% over the past 52 weeks.